TELA Bio (TELA) Property, Plant & Equipment (Net) Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 8.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37% |
| Dec 31, 2025 | 9.79% |
| Sep 30, 2025 | 8.18% |
| Jun 30, 2025 | 8.30% |
| Mar 31, 2025 | 14.66% |
| Dec 31, 2024 | 25.44% |
| Sep 30, 2024 | 39.58% |
| Jun 30, 2024 | 56.83% |
| Mar 31, 2024 | 58.49% |
| Dec 31, 2023 | 46.89% |
| Sep 30, 2023 | 38.95% |
| Jun 30, 2023 | 37.54% |
| Mar 31, 2023 | 34.73% |
| Dec 31, 2022 | 35.44% |
| Sep 30, 2022 | 34.65% |
| Dec 31, 2021 | 16.09% |